method and kit for selectively quantifying and / or characterizing a-beta aggregates; method for determining the efficacy of active substances and / or therapies for the treatment of ad; method for deciding on the acceptance of an individual under study or clinical trial; probes; and use of α-beta aggregate specific probes or α-beta oligomer specific probes

摘要

summary method and kit for selectively quantifying and / or characterizing a-beta aggregates; method for determining the efficacy of active substances and / or therapies for the treatment of ad; method for deciding on the acceptance of an individual under study or clinical trial; probes; and use of specific α-beta aggregate probes or α-beta oligomer-specific probes The invention relates to methods for selectively quantifying α-beta aggregates comprising immobilizing anti-α-beta antibodies on a substrate, applying a sample to be tested on the substrate, addition of labeled detection probes, which label these by specific binding to α-beta aggregates and detection of labeled aggregates. 1/1